- Research works
- 4 ▲ 100% vs 2013–17
- Citations
- 116 27.0 per fractional work
- Top-10% rate
- 0.0% record average 16.5%
- Open access
- 21% world 28%
Not ranked overall: Genapsys (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Which research topics does Genapsys (United States) publish most on?
By volume in 2022–2025: CRISPR and Genetic Engineering.
- 1 CRISPR and Genetic Engineering Molecular Biology 1 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
How has Genapsys (United States)'s research output changed?
Output in 2018–2022 was 100% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Redwood City
- Heron Therapeutics (United States)
- Chan Zuckerberg Initiative (United States)
- Emergency University
- Guardant (United States)
- Box (United States)
- OncoMed (United States)
- Genomic Health (United States)
- Ubiquitous Energy (United States)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.